Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2000 participants
OBSERVATIONAL
2024-10-02
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Oral Feeding on Gastric Emptying, Gut Blood Flow, and Hormone Responses in Obese and Healthy Weight Subjects
NCT03860623
Analyses of Malnutrition Screening in Internal Medicine
NCT05918900
The Netherlands Epidemiology of Obesity Study
NCT03410316
Neuromolecular Risk Factors for Obesity (PROSPECT)
NCT03106688
Body Fat Distribution and Fat Metabolism
NCT00475774
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This project has the following objectives:
* To evaluate the nutritional status (malnutrition, overweight, and the combination of both) and the (dietary) treatment of patients with COVID-19 in primary care (WP1).
* To assess the influence of various parameters of malnutrition and overweight and their effects on the outcomes of COVID-19 and cancer based on literature and data from existing Dutch cohorts (WP2 and WP3).
Based on this, to develop a screening tool for malnutrition in overweight; (WP4).
\- Dissemination of the results (WP5).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with overweight or obesity
Inclusion criteria:
* Age 18 years or older
* Overweight (BMI of 25 kg/m² or higher)
Exclusion criteria:
* Physically or mentally unable to participate.
* Severe cognitive disorder or severe emotional instability, as assessed by the attending nurse or physician.
* Insufficient proficiency in the Dutch language to express themselves properly and no interpreter or assistant to help.
* Patient resides in a nursing or care home.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Overweight (BMI of 25 kg/m² or higher)
Exclusion Criteria
* Severe cognitive disorder or severe emotional instability, as assessed by the attending nurse or physician.
* Insufficient proficiency in the Dutch language to express themselves properly and no interpreter or assistant to help.
* Patient resides in a nursing or care home.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Amsterdam University of Applied Sciences
OTHER
National Institute for Public Health and the Environment (RIVM)
OTHER_GOV
Erasmus Medical Center
OTHER
Wageningen University and Research
OTHER
Gelderse Vallei Hospital
OTHER
Amsterdam UMC, location VUmc
OTHER
Amsterdam UMC, location AMC
OTHER
HAN University of Applied Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
dr. Marian de van der Schueren
Professor of Nutrition, Dietetics and Lifestyle
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
OLVG
Amsterdam, , Netherlands
Ziekenhuis Gelderse Vallei
Ede, , Netherlands
ErasmusMC
Rotterdam, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Carliene van Dronkelaar, PhD
Role: primary
Emmelyne Vasse, PhD
Role: primary
Joanne Olieman, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
6496655
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
SCOOP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.